Inan Olmez

Pediatric Neurology

500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in Glioblastoma.

BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in Glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: January 08, 2026

Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.

Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.

Journal: Cancers

Published: May 09, 2024

Statins affect human glioblastoma and other cancers through TGF-β inhibition.

Statins affect human glioblastoma and other cancers through TGF-β inhibition.

Journal: Oncotarget

Published: September 18, 2018

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.

Journal: Neuro-oncology

Published: October 20, 2017

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Journal: Cancer research

Published: October 10, 2017

A randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patients.

A randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patients.

Journal: Pediatric blood & cancer

Published: April 11, 2017

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 20, 2017

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

Journal: Oncotarget

Published: March 10, 2017

Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.

Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.

Journal: Journal of cellular and molecular medicine

Published: July 13, 2014

Adult-onset adrenoleukodystrophy presenting after chemotherapy: No black and white matter.

Adult-onset adrenoleukodystrophy presenting after chemotherapy: No black and white matter.

Journal: Neurology. Clinical practice

Published: April 01, 2014

Diagnostic and therapeutic aspects of Hashimoto's encephalopathy.

Diagnostic and therapeutic aspects of Hashimoto's encephalopathy.

Journal: Journal of the neurological sciences

Published: November 27, 2012

Analysis of significant decrease in platelet count and thrombocytopenia, graded according to NCI-CTC, as prognostic risk markers for mortality and morbidity.

Analysis of significant decrease in platelet count and thrombocytopenia, graded according to NCI-CTC, as prognostic risk markers for mortality and morbidity.

Journal: Journal of pediatric hematology/oncology

Published: November 02, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026